Those who receive the COVID-19 vaccine during pregnancy are less likely to be hospitalized for COVID-19; however, vaccine uptake in this population is suboptimal.

The mRNA-1273 COVID-19 booster dose was safe and elicited robust immune responses among children aged 6 months to 5 years and 6 to 11 years.

Emotional dysregulation is more severe among individuals with ASD than neurotypical peers and those with other clinical conditions.

Childhood attention-deficit/hyperactivity disorder (ADHD) is associated with impaired cognitive functioning in adulthood.

Influenza vaccination in successive pregnancies is not associated with increased risk for prespecified adverse perinatal outcomes.

COVID-19 vaccination was associated with a lower incidence of mental illnesses, like depression, following COVID-19 infection.

Following COVID-19 vaccination, most patients with MS do not face an increased risk for relapse requiring corticosteroid therapy.

A mailed knowledge mobilization and behavior change intervention can reduce the use of sedatives and improve sleep outcomes in older adults with insomnia.

Ketamine treatment among patients with fibromyalgia may offer short-term pain relief, though its long-term efficacy and safety remain uncertain.

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

Parathyroidectomy vs nonoperative management was not associated with a reduced risk for depression among patients with hyperparathyroidism.

Frailty is an independent risk factor for increased rates of readmission and inpatient mortality among hospitalized patients with SLE.